Advertisement

Topics

Indivior Presents Results From The Phase III Pivotal Study Of RBP-6000 Buprenorphine Monthly Depot For The Treatment Of Opioid Use Disorder

20:00 EDT 21 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Indivior Presents Results From The Phase III Pivotal Study Of RBP-6000 Buprenorphine Monthly Depot For The Treatment Of Opioid Use Disorder

NEXT ARTICLE

More From BioPortfolio on "Indivior Presents Results From The Phase III Pivotal Study Of RBP-6000 Buprenorphine Monthly Depot For The Treatment Of Opioid Use Disorder"

Advertisement
Quick Search
Advertisement
Advertisement